Pipeline Review on Genzyme Corporation - Product Industry 2014

1
Genzyme Corporation - Product Pipeline Review -
2014
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published January 2014
• Single User PDF US 1500
• Corporate User PDF US 4500

2
Genzyme Corporation - Product Pipeline Review -
2014

• Genzyme Corporation Product Pipeline Review 2014"
  provides data on the Genzyme Corporation's
  research and development focus. The report
  includes information on current developmental
  pipeline, complete with latest updates, and
  features on discontinued and dormant projects.
• This report is built using data and information
  sourced from proprietary databases, Genzyme
  Corporation's corporate website, SEC filings,
  investor presentations and featured press
  releases, both from Genzyme Corporation and
  industry-specific third party sources.
• Inquiry Before Buying on this Report _at_
  http//www.reportsnreports.com/contacts/inquirybef
  orebuy.aspx?name274871.
• Scope
• Genzyme Corporation Brief Genzyme Corporation
  overview including business description, key
  information and facts, and its locations and
  subsidiaries.
• Review of current pipeline of Genzyme Corporation
  human therapeutic division.
• Overview of pipeline therapeutics across various
  therapy areas.
• Coverage of current pipeline molecules in various
  stages of drug development, including the
  combination treatment modalities, across the
  globe.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Genzyme Corporation - Product Pipeline Review -
2014

• Product profiles for late stage and clinical
  stage products of Genzyme Corporation with
  complete description of the product's
  developmental history, mechanism of action,
  therapeutic class, target and major milestones.
• Recent updates of the Genzyme Corporation's
  pipeline in the last quarter.
• Key discontinued and dormant projects.
• Latest news and deals relating to the products.
• Inquire for Discount _at_ http//www.reportsnreports.
  com/contacts/discount.aspx?name274871.
• Reasons to buy
• Evaluate Genzyme Corporation's strategic position
  with total access to detailed information on its
  product pipeline.
• Assess the growth potential of Genzyme
  Corporation in its therapy areas of focus.
• Identify new drug targets and therapeutic classes
  in the Genzyme Corporation's RD portfolio and
  develop key strategic initiatives to reinforce
  pipeline in those areas.
• Exploit in-licensing opportunities by identifying
  windows of opportunity to fill portfolio gaps.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Genzyme Corporation - Product Pipeline Review -
2014

• Exploit collaboration and partnership
  opportunities with Genzyme Corporation.
• Avoid Intellectual Property Rights related
  issues.
• Explore the dormant and discontinued projects of
  Genzyme Corporation and identify potential
  opportunities in those areas.
• List of Tables
• Genzyme Corporation, Key Information 6Genzyme
  Corporation, Key Facts 6Genzyme Corporation -
  Pipeline by Indication, 2014 8Genzyme
  Corporation - Pipeline by Stage of Development,
  2014 10Genzyme Corporation - Monotherapy
  Products in Pipeline, 2014 11Genzyme Corporation
  - Partnered Products in Pipeline, 2014 12Genzyme
  Corporation - Partnered Products/ Combination
  Treatment Modalities, 2014 13Genzyme Corporation
  - Pre-Registration, 2014 14Genzyme Corporation -
  Filing rejected/Withdrawn, 2014 15Genzyme
  Corporation - Phase III, 2014 16Genzyme
  Corporation - Phase II, 2014 17Genzyme
  Corporation - Phase I, 2014 18
• Genzyme Corporation - Preclinical, 2014 19

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Genzyme Corporation - Product Pipeline Review -
2014

• Genzyme Corporation - Discovery, 2014 20Genzyme
  Corporation - Unknown, 2014 21Genzyme
  Corporation - Pipeline by Therapeutic Class, 2014
  44Genzyme Corporation - Pipeline by Target, 2014
  47Genzyme Corporation - Pipeline by Route of
  Administration, 2014 48Genzyme Corporation -
  Pipeline by Molecule Type, 2014 50Genzyme
  Corporation - Pipeline Products by Mechanism of
  Action, 2014 52Genzyme Corporation - Recent
  Pipeline Updates, 2014 53Genzyme Corporation -
  Dormant Developmental Projects,2014 70Genzyme
  Corporation - Discontinued Pipeline Products,
  2014 73Genzyme Corporation, Other Locations
  75Genzyme Corporation, Subsidiaries 81Genzyme
  Corporation, Key Manufacturing Facilities 84
• List of Figures
• Genzyme Corporation - Pipeline by Top 10
  Indication, 2014 8Genzyme Corporation - Pipeline
  by Stage of Development, 2014 10Genzyme
  Corporation - Monotherapy Products in Pipeline,
  2014 11Genzyme Corporation - Partnered Products
  in Pipeline, 2014 12

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
Genzyme Corporation - Product Pipeline Review -
2014

• Genzyme Corporation - Pipeline by Top 10
  Therapeutic Class, 2014 43Genzyme Corporation -
  Pipeline by Top 10 Target, 2014 46Genzyme
  Corporation - Pipeline by Top 10 Route of
  Administration, 2014 48Genzyme Corporation -
  Pipeline by Top 10 Molecule Type, 2014 49Genzyme
  Corporation - Pipeline Products by Top 10
  Mechanism of Action, 2014 51
• Contact  sales_at_reportsandreports.com  / Call 1
  888 391 5441 for further information on Genzyme
  Corporation - Product Pipeline Review - 2014
  report OR for any other market research and
  intelligence needs you may have for your business.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.